Evidence map›Paper›PMID 42254222›Full record

ArticleAnnals of medicine and surgery (2012)2026

Subtotal resection and adjuvant radiotherapy for a fourth ventricle rosette-forming glioneuronal tumor in a child: a case report and review of management strategies.

Oualid Mohammed Hmamouche, Marouane Hammoud, Badereddine Mohammadine, Faycal Lakhdar, Mohammed Benzagmout, Khalid Chakour, Mohammed El Faiz Chaoui

Abstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oualid Mohammed HmamoucheDepartment of Neurosurgery, Hassan II University Hospital of Fez, Morocco.ORCID https://orcid.org/0000-0001-9907-391X
Marouane HammoudDepartment of Neurosurgery, Hassan II University Hospital of Fez, Morocco.
Badereddine MohammadineDepartment of Neurosurgery, Hassan II University Hospital of Fez, Morocco.
Faycal LakhdarDepartment of Neurosurgery, Hassan II University Hospital of Fez, Morocco.
Mohammed BenzagmoutDepartment of Neurosurgery, Hassan II University Hospital of Fez, Morocco.
Khalid ChakourDepartment of Neurosurgery, Hassan II University Hospital of Fez, Morocco.
Mohammed El Faiz ChaouiDepartment of Neurosurgery, Hassan II University Hospital of Fez, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction and importance: Rosette-forming glioneuronal tumor (RGNT) is a rare World Health Organization grade I tumor of the central nervous system, most commonly found in the fourth ventricle. Preoperative diagnosis is challenging, and optimal management for incompletely resected tumors is not well-established. Case presentation: An 8-year-old boy presented with headaches and declining vision due to obstructive hydrocephalus caused by a large fourth ventricle tumor with extension into the cerebellopontine angle. After an endoscopic third ventriculostomy, the patient underwent maximal safe subtotal resection. Histopathological examination confirmed RGNT. Given the residual tumor, adjuvant radiotherapy was administered. Following treatment, the patient's symptoms resolved, and follow-up imaging demonstrated stable residual disease. Clinical discussion: Although RGNTs are indolent tumors, their location in the fourth ventricle often precludes complete resection. Subtotal resection followed by adjuvant radiotherapy Conclusion: This case highlights the importance of

Indexed as

case reportchildfourth ventricleglioneuronalRGNTrosette-forming

Identifiers

PMID42254222
PMCPMC13236300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.